Rosen B - Search Results

1

Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes.

Akbari MR, Zhang S, Fan I, Royer R, Li S, Risch H, McLaughlin J, Rosen B, Sun P, Narod SA. Akbari MR, et al. Among authors: rosen b. J Med Genet. 2011 Nov;48(11):783-6. doi: 10.1136/jmedgenet-2011-100305. Epub 2011 Oct 1. J Med Genet. 2011. PMID: 21965345

2

Linkage analysis of 26 Canadian breast and breast-ovarian cancer families.

Tonin P, Moslehi R, Green R, Rosen B, Cole D, Boyd N, Cutler C, Margolese R, Carter R, McGillivray B, et al. Tonin P, et al. Among authors: rosen b. Hum Genet. 1995 May;95(5):545-50. doi: 10.1007/BF00223867. Hum Genet. 1995. PMID: 7759076

3

Hereditary and familial ovarian cancer in southern Ontario.

Narod SA, Madlensky L, Bradley L, Cole D, Tonin P, Rosen B, Risch HA. Narod SA, et al. Among authors: rosen b. Cancer. 1994 Oct 15;74(8):2341-6. doi: 10.1002/1097-0142(19941015)74:8<2341::aid-cncr2820740819>3.0.co;2-z. Cancer. 1994. PMID: 7922985

4

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.

Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA. Moslehi R, et al. Among authors: rosen b. Am J Hum Genet. 2000 Apr;66(4):1259-72. doi: 10.1086/302853. Epub 2000 Mar 16. Am J Hum Genet. 2000. PMID: 10739756 Free PMC article.

5

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA. Risch HA, et al. Among authors: rosen b. Am J Hum Genet. 2001 Mar;68(3):700-10. doi: 10.1086/318787. Epub 2001 Feb 15. Am J Hum Genet. 2001. PMID: 11179017 Free PMC article.

6

A genetic epidemiological study of carcinoma of the fallopian tube.

Aziz S, Kuperstein G, Rosen B, Cole D, Nedelcu R, McLaughlin J, Narod SA. Aziz S, et al. Among authors: rosen b. Gynecol Oncol. 2001 Mar;80(3):341-5. doi: 10.1006/gyno.2000.6095. Gynecol Oncol. 2001. PMID: 11263928

7

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.

Narod SA, Sun P, Ghadirian P, Lynch H, Isaacs C, Garber J, Weber B, Karlan B, Fishman D, Rosen B, Tung N, Neuhausen SL. Narod SA, et al. Among authors: rosen b. Lancet. 2001 May 12;357(9267):1467-70. doi: 10.1016/s0140-6736(00)04642-0. Lancet. 2001. PMID: 11377596

8

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.

Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, Warner E, Rosen B, Rebbeck T, Tonin P, Dubé MP, Kieback DG, Narod SA. Runnebaum IB, et al. Among authors: rosen b. Pharmacogenetics. 2001 Oct;11(7):635-8. doi: 10.1097/00008571-200110000-00010. Pharmacogenetics. 2001. PMID: 11668223

9

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status.

Colgan TJ, Murphy J, Cole DE, Narod S, Rosen B. Colgan TJ, et al. Among authors: rosen b. Am J Surg Pathol. 2001 Oct;25(10):1283-9. doi: 10.1097/00000478-200110000-00009. Am J Surg Pathol. 2001. PMID: 11688463

10

Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy.

Colgan TJ, Boerner SL, Murphy J, Cole DE, Narod S, Rosen B. Colgan TJ, et al. Among authors: rosen b. Gynecol Oncol. 2002 Jun;85(3):397-403. doi: 10.1006/gyno.2002.6638. Gynecol Oncol. 2002. PMID: 12051865 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,905 results

Search Page